Summary
The treatment was created in India by scientists from Indian Institute of Technology Bombay, Tata Memorial Centre and ImmunoACT.
It costs about one‑tenth of similar treatments made in other countries.
Key Points
4 points1
The soldier had B‑cell acute lymphoblastic leukemia, a serious blood cancer.
2
Chimeric antigen receptor T‑cell therapy teaches the patient’s T‑cells to recognise and kill cancer cells.
3
The therapy uses a human‑derived design, lowering the chance of serious side effects.
4
India’s first home‑made version makes the treatment more affordable for many patients.
New Words to Learn
5 wordsB‑cell acute lymphoblastic leukemia
a type of blood cancer that affects certain white blood cells
chimeric antigen receptor
a tiny tool added to cells so they can spot and attack cancer
T‑cells
a kind of immune cell that helps protect the body
re‑programming
changing how a cell works to give it a new job
clinical
related to doctors and medical treatment
Want to learn even more? Click here to read the full story!
🔊 Reading Article
Kid-friendly voice